Page 85 - MI-1-2
P. 85

Microbes & Immunity                                          Hydrogen alleviates non-alcoholic fatty liver disease



               acidophilus LA5 improves saturated fat-induced obesity   19.  Younossi ZM, Stepanova M, Negro F,  et al. Nonalcoholic
               mouse model through the enhanced intestinal Akkermansia   fatty liver disease in lean individuals in the United States.
               muciniphila. Sci Rep. 2021;11(1):6367.             Medicine (Baltimore). 2012;91(6):319-327.
               doi: 10.1038/s41598-021-85449-2                    doi: 10.1097/MD.0b013e3182779d49
            9.   Reunanen J, Kainulainen V, Huuskonen L, et al. Akkermansia   20.  Hotamisligil GS. Inflammation, metaflammation and
               muciniphila adheres to enterocytes and strengthens the   immunometabolic disorders. Nature. 2017;542(7640):177-185.
               integrity of the epithelial cell layer. Appl Environ Microbiol.
               2015;81:3655-3662.                                 doi: 10.1038/nature21363
                                                               21.  Bugianesi  E,  Moscatiello  S,  Ciaravella  MF,  Marchesini  G.
               doi: 10.1128/AEM.04050-14
                                                                  Insulin resistance in nonalcoholic fatty liver disease. Curr
            10.  Zhang L, Yu H, Tu Q, He Q, Huang N. New approaches   Pharm Des. 2010;16:1941-1951.
               for hydrogen therapy of various diseases. Curr Pharm Des.
               2021;27:636-649.                                   doi: 10.2174/138161210791208875
               doi: 10.2174/1381612826666201211114141          22.  Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte
                                                                  dysfunctions linking obesity to insulin resistance and type 2
            11.  Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as   diabetes. Nat Rev Mol Cell Biol. 2008;9(5):367-377.
               a therapeutic antioxidant by selectively reducing cytotoxic
               oxygen radicals. Nat Med. 2007;13:688-694.         doi: 10.1038/nrm2391
               doi: 10.1038/nm1577                             23.  Chopyk DM, Grakoui A. Contribution of the Intestinal
                                                                  microbiome and gut barrier to hepatic disorders.
            12.  Ostojic SM. Hydrogen as a potential therapeutic in   Gastroenterology. 2020;159(3):849-863.
               obesity: Targeting the Brain.  Trends  Endocrinol Metab.
               2021;32:191-193.                                   doi: 10.1053/j.gastro.2020.04.077
               doi: 10.1016/j.tem.2021.01.002                  24.  Derrien M, Vaughan EE, Plugge CM, De Vos WM.
                                                                  Akkermansia muciniphila gen.  nov., sp. nov.,  a human
            13.  Chen KD, Lin WC, Kuo HC. Chemical and biochemical   intestinal mucin-degrading bacterium.  Int  J  Syst  Evol
               aspects of molecular hydrogen in treating Kawasaki disease   Microbiol. 2004;54(Pt 5):1469-1476.
               and COVID-19. Chem Res Toxicol. 2021;34:952-958.
                                                                  doi: 10.1099/ijs.0.02873-0.
               doi: 10.1021/acs.chemrestox.0c00456
                                                               25.  Derrien M, Van Passel MW, Van de Bovenkamp JH,
            14.  Liu B, Xue J, Zhang M, et al. Hydrogen inhalation alleviates   Schipper  RG, De Vos WM, Dekker J. Mucin-bacterial
               nonalcoholic fatty liver disease in metabolic syndrome rats.   interactions in the human oral cavity and digestive tract. Gut
               Mol Med Rep. 2020;22(4):2860-2868.                 Microbes. 2010;1(4):254-268.
               doi: 10.3892/mmr.2020.11364                        doi: 10.4161/gmic.1.4.12778
            15.  Li SW, Takahara T, Que W,  et al. Hydrogen-rich water   26.  Lagier JC, Hugon P, Khelaifia S, Fournier PE, La Scola B,
               protects against liver injury in nonalcoholic steatohepatitis   Raoult D. The rebirth of culture in microbiology through the
               through HO-1 enhancement via IL-10 and Sirt 1 signaling.   example of culturomics to study human gut microbiota. Clin
               Am J Physiol Gastrointest Liver Physiol. 2021;320:G450-G463.  Microbiol Rev. 2015;28(1):237-264.
               doi: 10.1152/ajpgi.00158.2020                      doi: 10.1128/CMR.00014-14
            16.  Xue J, Zhao M, Liu Y, et al. Hydrogen inhalation ameliorates   27.  Derrien M, Collado MC, Ben-Amor K, Salminen S, De
               hepatic inflammation and modulates gut microbiota in rats   Vos WM. The Mucin degrader Akkermansia muciniphila
               with high-fat diet-induced non-alcoholic fatty liver disease.   is an abundant resident of the human intestinal tract. Appl
               Eur J Pharmacol. 2023;947:175698.                  Environ Microbiol. 2008;74(5):1646-1648.
               doi: 10.1016/j.ejphar.2023.175698
                                                                  doi: 10.1128/AEM.01226-07
            17.  Wu Z, Huang S, Li T,  et al. Gut microbiota from green   28.  Paone P, Cani PD. Mucus barrier, mucins and gut microbiota:
               tea polyphenol-dosed mice improves intestinal epithelial   The expected slimy partners? Gut. 2020;69(12):2232-2243.
               homeostasis  and  ameliorates  experimental  colitis.
               Microbiome. 2021;9:184.                            doi: 10.1136/gutjnl-2020-322260
               doi: 10.1186/s40168-021-01115-9                 29.  Ouyang J, Lin J, Isnard S, et al. The bacterium Akkermansia
                                                                  muciniphila: A sentinel for gut permeability and its relevance
            18.  Zhang X, Coker OO, Chu ES,  et al. Dietary cholesterol
               drives fatty liver-associated liver cancer by modulating gut   to HIV-related inflammation. Front Immunol. 2020;11:645.
               microbiota and metabolites. Gut. 2021;70(4):761-774.     doi: 10.3389/fimmu.2020.00645
               doi: 10.1136/gutjnl-2019-319664                 30.  Berry D, Schwab C, Milinovich G, et al. Phylotype-level 16S


            Volume 1 Issue 2 (2024)                         79                               doi: 10.36922/mi.3896
   80   81   82   83   84   85   86   87   88   89   90